![John Milligan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Milligan
Presidente presso
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Patrimonio netto: 1 M $ in data 31/05/2026
Profilo
Il dottor John F. Milligan è presidente esecutivo della 4D Molecular Therapeutics, Inc. e presidente della Pacific Biosciences of California, Inc. Fa parte del consiglio di amministrazione della Biotechnology Innovation Organization e della Ohio Wesleyan University. Il Dr. Milligan è stato precedentemente impiegato come Presidente di Pharmasset, Inc., Direttore-Project Management di Hoffmann-La Roche, Inc. e Presidente, Amministratore Delegato e Direttore di Gilead Sciences, Inc. Si è laureato alla Ohio Wesleyan University e ha conseguito il dottorato alla University of Illinois.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/06/2026 | 100.000 ( 0,19% ) | 991 000 $ | 31/05/2026 | |
| 03/06/2026 | 132.821 ( 0,04% ) | 197 903 $ | 31/05/2026 | |
-.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di John Milligan
| Società | Posizione | Inizio |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Presidente | 14/09/2020 |
| 4D MOLECULAR THERAPEUTICS, INC. | Presidente | 01/08/2020 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direttore/Membro del Consiglio | 22/07/2011 |
TurnCare, Inc.
 TurnCare, Inc. Packaged SoftwareTechnology Services Develops unique technology that enhances skin and soft tissue circulation | Direttore/Membro del Consiglio | 01/12/2023 |
Precedenti posizioni note di John Milligan
| Società | Posizione | Fine |
|---|---|---|
| GILEAD SCIENCES, INC. | Amministratore Delegato | 31/12/2018 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Presidente | - |
Ohio Wesleyan University
 Ohio Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Presidente | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Formazione di John Milligan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pacific Biosciences of California, Inc.
 Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Ohio Wesleyan University
Ohio Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
TurnCare, Inc.
TurnCare, Inc. Packaged SoftwareTechnology Services Develops unique technology that enhances skin and soft tissue circulation | Technology Services |
